Growth Metrics

Tarsus Pharmaceuticals (TARS) Other Accumulated Expenses (2020)

Historic Other Accumulated Expenses for Tarsus Pharmaceuticals (TARS) over the last 1 years, with Q3 2020 value amounting to $447000.0.